4.6 Article

Proteasome Inhibitor PS-341 Effectively Blocks Infection by the Severe Fever with Thrombocytopenia Syndrome Virus

Related references

Note: Only part of the references are listed.
Review Infectious Diseases

Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy

Masayuki Saijo

JOURNAL OF INFECTION AND CHEMOTHERAPY (2018)

Article Pharmacology & Pharmacy

Characterizing the effect of Bortezomib on Rift Valley Fever Virus multiplication

Forrest Keck et al.

ANTIVIRAL RESEARCH (2015)

Article Immunology

Severe fever with thrombocytopenia syndrome and its pathogen SFTSV

Xiao-Ying Lei et al.

MICROBES AND INFECTION (2015)

Article Virology

The Antiviral Effect of Baicalin on Enterovirus 71 In Vitro

Xiang Li et al.

VIRUSES-BASEL (2015)

Article Virology

Influenza virus-host interactomes as a basis for antiviral drug development

Tokiko Watanabe et al.

CURRENT OPINION IN VIROLOGY (2015)

Article Infectious Diseases

Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection

Milly M. Choy et al.

PLOS NEGLECTED TROPICAL DISEASES (2015)

Review Infectious Diseases

Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis

Quan Liu et al.

LANCET INFECTIOUS DISEASES (2014)

Editorial Material Medicine, General & Internal

Severe Fever with Thrombocytopenia Syndrome: Tick-Mediated Viral Disease

Mee Soo Chang et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2013)

Article Medicine, General & Internal

Fever with Thrombocytopenia Associated with a Novel Bunyavirus in China

Xue-Jie Yu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Biochemistry & Molecular Biology

Mdm2-mediated ubiquitylation: p53 and beyond

J-C Marine et al.

CELL DEATH AND DIFFERENTIATION (2010)

Article Infectious Diseases

A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults

Vianney Tricou et al.

PLOS NEGLECTED TROPICAL DISEASES (2010)

Article Infectious Diseases

Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy

Stephan Ludwig

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)

Review Oncology

Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy

Mario Boccadoro et al.

CANCER CELL INTERNATIONAL (2005)

Article Oncology

Development of the proteasome inhihitor Veleade((TM)) (Bortezomib)

J Adams et al.

CANCER INVESTIGATION (2004)